{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T02:19:35Z","timestamp":1782181175411,"version":"3.54.5"},"reference-count":60,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010740","name":"Asahi Kasei Pharma Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010740","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014421","name":"EA Pharma Co., Ltd.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014421","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014422","name":"Eli Lilly Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012351","name":"Mitsubishi Tanabe Pharma Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012351","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010486","name":"Teijin Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010486","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010795","name":"Chugai Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010793","name":"Pfizer Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002336","name":"Daiichi Sankyo Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.autrev.2020.102642","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T21:51:39Z","timestamp":1597269099000},"page":"102642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Characteristics and prognosis of ANCA-positive retroperitoneal fibrosis: A systematic literature review"],"prefix":"10.1016","volume":"19","author":[{"given":"Mitsuhiro","family":"Akiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2020.102642_bb0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41584-018-0145-y","article-title":"Pathogenesis and therapeutic interventions for ANCA-associated vasculitis","volume":"15","author":"Nakazawa","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2020.102642_bb0010","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nrrheum.2016.123","article-title":"ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients","volume":"12","author":"Cornec","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2020.102642_bb0015","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrrheum.2017.140","article-title":"Position paper: revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis","volume":"13","author":"Bossuyt","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2020.102642_bb0020","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.3389\/fimmu.2019.02855","article-title":"Personalized medicine in ANCA-associated Vasculitis ANCA specificity as the guide?","volume":"10","author":"Wallace","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2020.102642_bb0025","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/rheumatology\/kez016","article-title":"Clinical impact of subgrouping ANCA-associated vasculitis according to antibody specificity beyond the clinicopathological classification","volume":"58","author":"Deshayes","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2020.102642_bb0030","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.semarthrit.2018.05.003","article-title":"Myeloperoxidase-ANCA-positive granulomatosis with polyangiitis is a distinct subset of ANCA-associated vasculitis: a retrospective analysis of 455 patients from a single center in China","volume":"48","author":"Chang","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102642_bb0035","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1002\/art.39786","volume":"68","author":"Schirmer","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2020.102642_bb0040","article-title":"All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type","author":"Wallace","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2020.102642_bb0045","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.semarthrit.2018.05.005","article-title":"Frequency, treatment, evolution, and factors associated with the presence of tracheobronchial stenoses in granulomatosis with polyangiitis. Retrospective analysis of a case series from a single respiratory referral center","volume":"48","author":"Marroqu\u00edn-Fabi\u00e1n","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102642_bb0050","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.3389\/fimmu.2019.02617","article-title":"Neutrophil extracellular traps induce tissue-invasive monocytes in granulomatosis with Polyangiitis","volume":"10","author":"Akiyama","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2020.102642_bb0055","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1093\/rheumatology\/kez217","article-title":"Subglottic stenosis and endobronchial disease in granulomatosis with polyangiitis","volume":"58","author":"Quinn","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2020.102642_bb0060","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.semarthrit.2017.12.002","article-title":"Bronchiectasis is highly prevalent in anti-MPO ANCA-associated vasculitis and is associated with a distinct disease presentation","volume":"48","author":"N\u00e9el","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102642_bb0065","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.semarthrit.2017.07.004","article-title":"The BVAS is an independent predictor of cardiovascular events and cardiovascular disease-related mortality in patients with ANCA-associated vasculitis: a study of 504 cases in a single Chinese center","volume":"47","author":"Bai","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102642_bb0070","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nrrheum.2011.184","article-title":"Vasculitis syndromes: peripheral neuropathy in AAV--when vasculitis hits a nerve","volume":"8","author":"Rutgers","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2020.102642_bb0075","doi-asserted-by":"crossref","first-page":"e0521","DOI":"10.1097\/MD.0000000000010521","article-title":"Adolescent PR3-ANCA-positive hypertrophic pachymeningitis: A case report and review of the literature","volume":"97","author":"Matsumoto","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2020.102642_bb0080","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/ICU.0b013e32834bdfe2","article-title":"Ocular manifestations of systemic disease: antineutrophil cytoplasmic antibody-associated vasculitis","volume":"22","author":"Schmidt","year":"2011","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.autrev.2020.102642_bb0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.21053\/ceo.2016.9.1.8","article-title":"Granulomatosis with Polyangiitis in otolaryngologist practice: a review of current knowledge","volume":"9","author":"Wojciechowska","year":"2016","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"10.1016\/j.autrev.2020.102642_bb0090","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s12016-017-8616-5","article-title":"Cutaneous manifestations of ANCA-associated small vessels Vasculitis","volume":"53","author":"Marzano","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2020.102642_bb0095","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1046\/j.1365-2796.2002.00948.x","article-title":"ANCA-positive periaortic vasculitis: does it fall within the spectrum of vasculitis?","volume":"251","author":"Vaglio","year":"2002","journal-title":"J Intern Med"},{"key":"10.1016\/j.autrev.2020.102642_bb0100","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11739-016-1599-z","article-title":"Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease","volume":"12","author":"Rossi","year":"2017","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.autrev.2020.102642_bb0105","doi-asserted-by":"crossref","first-page":"rky050","DOI":"10.1093\/rap\/rky050","article-title":"Retroperitoneal fibrosis; a single-centre case experience with literature review","volume":"3","author":"Adnan","year":"2018","journal-title":"Rheumatol Adv Pract"},{"key":"10.1016\/j.autrev.2020.102642_bb0110","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/annrheumdis-2018-214603","article-title":"ACR\/EULAR IgG4- RD Classification Criteria Committee. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts","volume":"78","author":"Wallace","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102642_bb0115","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40266-018-0534-6","article-title":"IgG4-related disease: beyond glucocorticoids","volume":"35","author":"Akiyama","year":"2018","journal-title":"Drugs Aging"},{"key":"10.1016\/j.autrev.2020.102642_bb0120","doi-asserted-by":"crossref","first-page":"e10935","DOI":"10.1097\/MD.0000000000010935","article-title":"IgG4-related fibrosing mediastinitis diagnosed with computed tomography-guided percutaneous needle biopsy: Two case reports and a review of the literature","volume":"97","author":"Takanashi","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2020.102642_bb0125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12026-019-9070-7","article-title":"Consideration concerning similarities and differences between ANCA-associated vasculitis and IgG-4- related diseases: case series and review of literature","volume":"67","author":"Kawashima","year":"2019","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2020.102642_bb0130","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/1756-185X.12687","article-title":"Medical mirroring: granulomatosis with polyangiitis (formerly Wegener's) mimicking immunoglobulin-G4 related disease","volume":"21","author":"Kaushik","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102642_bb0135","first-page":"121","article-title":"Retroperitoneal fibrosis with periaortitis: a case report of an unusual form of presentation of granulomatosis with polyangiitis","volume":"19","author":"Gonz\u00e1lez Revilla","year":"2016","journal-title":"Respir Med Case Rep"},{"key":"10.1016\/j.autrev.2020.102642_bb0140","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2169\/internalmedicine.51.6599","article-title":"Proteinase 3 anti-neutrophil cytoplasmic antibody (PR3-ANCA) positive IgG4-related retroperitoneal fibrosis: utility of PET-CT with 18F-fluorodeoxy glucose (FDG)","volume":"51","author":"Kotani","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2020.102642_bb0145","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2169\/internalmedicine.50.4593","article-title":"IgG4-related systemic disease in a native American man","volume":"50","author":"Patel","year":"2011","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2020.102642_bb0150","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3109\/s10165-011-0456-1","article-title":"Epidural spinal tumor and periaortitis as rare complications of Wegener's granulomatosis","volume":"21","author":"Kasagi","year":"2011","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2020.102642_bb0155","doi-asserted-by":"crossref","first-page":"251","DOI":"10.5414\/CNP70251","article-title":"Association of idiopathic retroperitoneal fibrosis, rapidly progressive glomerulonephritis and antiproteinase 3 antineutrophil cytoplasmic antibodies (anti PR3-ANCA)","volume":"70","author":"Mart\u00ednez-Odriozola","year":"2008","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.autrev.2020.102642_bb0160","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10067-005-0118-9","article-title":"Retroperitoneal fibrosis and c-ANCA positivity","volume":"26","author":"Mavragani","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102642_bb0165","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/01.rhu.0000249863.76020.dd","article-title":"Wegener granulomatosis with back pain, periaortitis, and dural inflammation developing while receiving monthly cyclophosphamide","volume":"12","author":"Levin","year":"2006","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102642_bb0170","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0002-9343(03)00284-5","article-title":"Pseudotumoral retroperitoneal fibrosis and localized vasculitis with very high serum levels of anti-PR3 ANCA","volume":"115","author":"Aslangul","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2020.102642_bb0175","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0002-9343(03)00056-1","article-title":"Evidence of autoimmunity in chronic periaortitis: a prospective study","volume":"114","author":"Vaglio","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2020.102642_bb0180","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0953-6205(02)00096-1","article-title":"Retroperitoneal fibrosis and p- ANCA-associated polyarteritis nodosa: coincidental or common etiology?","volume":"13","author":"van Bommel","year":"2002","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.autrev.2020.102642_bb0185","first-page":"392","article-title":"Periaortitis heralding Wegener's granulomatosis","volume":"29","author":"de RS","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2020.102642_bb0190","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0002-9343(02)01170-1","article-title":"Retroperitoneal fibrosis due to Wegener's granulomatosis: a misdiagnosis as tuberculosis","volume":"113","author":"Izzedine","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2020.102642_bb0195","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000044915","article-title":"Retroperitoneal fibrosis with perinuclear antineutrophil cytoplasmic antibodies and a longitudinally extended periaortic soft-tissue structure on CT","volume":"78","author":"Sakemi","year":"1998","journal-title":"Nephron."},{"key":"10.1016\/j.autrev.2020.102642_bb0200","first-page":"779","article-title":"Retroperitoneal fibrosis with antineutrophil cytoplasmic antibodies","volume":"23","author":"Kaipiainen-Sepp\u00e4nen","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2020.102642_bb0205","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1159\/000187226","article-title":"Triple Wegener's granulomatosis in the urogenital tract","volume":"63","author":"ter Maaten","year":"1993","journal-title":"Nephron."},{"key":"10.1016\/j.autrev.2020.102642_bb0210","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MD.0b013e3181afc420","article-title":"Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation","volume":"88","author":"van Bommel","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2020.102642_bb0215","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.amjmed.2004.02.030","article-title":"The antineutrophil cytoplasmic antibody-associated vasculitides","volume":"117","author":"Seo","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2020.102642_bb0220","doi-asserted-by":"crossref","first-page":"102495","DOI":"10.1016\/j.autrev.2020.102495","article-title":"Clinical associations of renal involvement in ANCA-associated vasculitis","volume":"15","author":"Kronbichler","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102642_bb0225","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.autrev.2017.12.002","article-title":"Cellular immune regulation in the pathogenesis of ANCA-associated vasculitides","volume":"17","author":"von Borstel","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102642_bb0230","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.autrev.2017.11.011","article-title":"Cocaine and ANCA associated vasculitis-like syndromes - a case series","volume":"17","author":"Subesinghe","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102642_bb0235","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.autrev.2017.07.020","article-title":"Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: a new overlap syndrome","volume":"16","author":"Danlos","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102642_bb0240","doi-asserted-by":"crossref","first-page":"102354","DOI":"10.1016\/j.autrev.2019.102354","article-title":"Characteristics and prognosis of IgG4-related periaortitis\/periarteritis: a systematic literature review","volume":"18","author":"Akiyama","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102642_bb0245","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/1756-185X.13693","article-title":"Do ANCA-associated vasculitides and IgG4-related disease really overlap or not?","volume":"22","author":"Erden","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102642_bb0250","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s10157-019-01785-8","article-title":"Clinicopathological analysis of ANCA-associated glomerulonephritis focusing on plasma cell infiltrate","volume":"23","author":"Masuzawa","year":"2019","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.autrev.2020.102642_bb0255","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/1756-185X.13768","article-title":"Serum IgG4 level and IgG4 subclass of ANCA as disease biomarker for ANCA-associated vasculitis","volume":"23","author":"Akiyama","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102642_bb0260","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s10067-018-4402-x","article-title":"No overlap between IgG4-related disease and microscopic polyangiitis and granulomatosis with polyangiitis despite elevated serum IgG4 at diagnosis: a retrospective monocentric study","volume":"38","author":"Yoo","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102642_bb0265","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.18.20967","article-title":"Chest high- resolution CT findings of microscopic Polyangiitis: a Japanese first Nationwide prospective cohort study","author":"Suzuki","year":"2019","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.autrev.2020.102642_bb0270","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1681\/ASN.2015101110","article-title":"Idiopathic retroperitoneal fibrosis","volume":"27","author":"Vaglio","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2020.102642_bb0275","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/sj.ki.5002427","article-title":"Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis","volume":"72","author":"Corradi","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2020.102642_bb0280","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/rheumatology\/kex171","article-title":"Follicular helper T cells in the pathogenesis of IgG4-related disease","volume":"57","author":"Akiyama","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2020.102642_bb0285","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0002-9343(03)00056-1","article-title":"Evidence of autoimmunity in chronic periaortitis: a prospective study","volume":"114","author":"Vaglio","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2020.102642_bb0290","doi-asserted-by":"crossref","first-page":"102424","DOI":"10.1016\/j.autrev.2019.102424","article-title":"Complement alternative pathway in ANCA-associated vasculitis: two decades from bench to bedside","volume":"19","author":"Brilland","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102642_bb0295","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.autrev.2017.11.014","article-title":"Childhood- versus adult-onset ANCA-associated vasculitides: a nested, matched case-control study from the French Vasculitis study group registry","volume":"17","author":"Iudici","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102642_bb0300","doi-asserted-by":"crossref","first-page":"102514","DOI":"10.1016\/j.autrev.2020.102514","article-title":"Usefulness of vasculitis biomarkers in the era of the personalized medicine","volume":"12","author":"Csernok","year":"2020","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220302135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220302135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:19:26Z","timestamp":1761599966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997220302135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":60,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1568997220302135"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102642","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics and prognosis of ANCA-positive retroperitoneal fibrosis: A systematic literature review","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102642","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102642"}}